Online citations, reference lists, and bibliographies.
← Back to Search

Improved Absorption Of Salmon Calcitonin By Ultraflexible Liposomes Through Intranasal Delivery

Ming Chen, Xin-ru Li, Yan-xia Zhou, Ke-Wei Yang, Li-jun Ren
Published 2009 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The objective of this work was to explore the potential of ultraflexible liposomes as carriers for improving the absorption of salmon calcitonin (sCT) through intranasal administration. The average diameters of positively charged ultraflexible liposomes ranged from about 73 to 99 nm, while those of negatively charged ones were 114 and 157.6 nm, respectively. The content of sodium deoxycholate in liposomes markedly affected the size and encapsulated efficiency of liposomes. The absorption of sCT through intranasal administration was evaluated by hypocalcemic efficacy in rats. The total Ca decrease D% of sCT-loaded ultraflexible liposomes with positive and negative charges were significantly bigger than that of sCT solution, while there was no significant difference in the hypocalcemic efficacy between plain liposome and sCT solution. Unexpectedly, the hypocalcemic efficacy of sCT-loaded ultraflexible liposomes with positive charges was not significantly better than those with negative charges. The decrease rate and extent of the serum calcium level for subcutaneous injection of sCT solution were almost equivalent to those for intranasal administration of negatively and positively charged ultraflexible liposomes within the first 2h, indicating that the ultraflexible liposomes could quickly enhance the penetration of the drug during their residence in the nasal cavity. The results of the toxicity of sCT-loaded ultraflexible liposomes to nasal mucosa demonstrated that the ultraflexible liposomes exerted slight toxicity on the nasal mucosa. On an overall evaluation, the ultraflexible liposomes may be a useful vehicle for intranasal delivery of sCT.
This paper references
10.1152/AJPENDO.1979.236.1.E15
Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.
R. Huwyler (1979)
10.1016/S0928-0987(01)00094-X
Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin.
K. Morimoto (2001)
10.1016/J.EJPB.2006.05.005
Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
M. Tafaghodi (2006)
10.1016/S0168-3659(96)01566-0
Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo
G. Cevc (1997)
10.2165/00003088-200342050-00004
Transdermal Drug Delivery of Insulin with Ultradeformable Carriers
G. Cevc (2003)
10.1023/B:PHAR.0000026823.82950.ff
Nasal route and drug delivery systems
S. Türker (2004)
10.1016/S0168-3659(99)00285-0
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
S. T. Lim (2000)
10.1016/0378-5173(94)00296-H
Liposomes based nasal delivery system of nifedipine : development and characterization
S. Vyas (1995)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0005-2736(02)00401-7
Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements.
G. Cevc (2002)
10.1023/A:1018911206646
Drug Metabolism in the Nasal Mucosa
Mohamadi A. Sarkar (2004)
The frog palate for studying mucus transport velocity and mucociliary frequency.
E. Puchelle (1983)
10.1081/DDC-100102275
The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
K. Muramatsu (1999)
10.1016/S0378-5173(98)00346-9
Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract.
S. Sakuma (1999)
10.1016/0003-2697(91)90502-K
Analytical and micropreparative capillary electrophoresis of the peptides from calcitonin.
P. Camilleri (1991)
10.1016/0378-5173(95)04416-7
In vitro and in vivo nasal mucoadhesion of some water-soluble polymers
F. Nakamura (1996)
[Toxicity of drugs on nasal mucocilia and the method of its evaluation].
X. Jiang (1995)
10.1016/S0005-2736(03)00172-X
Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes.
G. Cevc (2003)
10.1016/8756-3282(95)00447-5
Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
G. Thamsborg (1996)
10.1248/CPB.40.1569
Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits.
Y. Maitani (1992)
10.1016/0378-5173(81)90009-0
Effect of surfactants on the nasal absorption of insulin in rats
Hirai Shinichiro (1981)
10.1016/0169-409X(95)00091-K
The skin: a pathway for systemic treatment with patches and lipid-based agent carriers
G. Cevc (1996)
STUDY ON TRANSNASAL ASPIRIN-dl LYSINE LIPOSOMES
Dong Ze (1995)
10.1016/0378-5173(94)00158-2
Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats
K. Morimoto (1995)
10.1023/A:1016463118748
The Influence of Drugs on Nasal Ciliary Movement
W. Hermens (2004)
The interaction between ultraflexible nano-liposome of salmon calcitonin and surfactants
L. Yan (2003)



This paper is referenced by
10.1007/978-3-642-37250-6_15
Nose as a Route for Drug Delivery
A. Serralheiro (2013)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
10.1016/j.jphotobiol.2017.07.007
Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo.
Sindhu Doppalapudi (2017)
10.1208/s12249-020-1619-1
Thermosensitive Hydrogel Based on Poly(2-Ethyl-2-Oxazoline)–Poly(D,L-Lactide)–Poly(2-Ethyl-2-Oxazoline) for Sustained Salmon Calcitonin Delivery
X. Wang (2020)
10.1016/j.ijpharm.2011.06.029
Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.
Yating Fan (2011)
10.3109/1061186X.2011.628397
Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art
C. Moutinho (2012)
10.1089/jamp.2013.1049
Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Janani Swaminathan (2014)
10.1016/j.biomaterials.2012.08.070
Airway delivery of peptides and proteins using nanoparticles.
C. Dombu (2013)
10.1016/B978-0-323-18907-1.00058-5
Chapter 58 – Calcitonin
D. Findlay (2016)
10.1016/j.ijbiomac.2016.09.027
Composite chitosan-transfersomal vesicles for improved transnasal permeation and bioavailability of verapamil.
Mamdouh. Abdel Mouez (2016)
10.1016/j.ijpharm.2009.10.031
Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
L. D. du Plessis (2010)
10.1007/s11060-017-2681-8
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model
N. Louis (2017)
10.1016/j.biomaterials.2012.08.047
The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
N. Li (2012)
10.1021/bm500169p
Drug carriers for the delivery of therapeutic peptides.
A. W. Du (2014)
10.3109/08982104.2013.826242
Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel
Ž. Vanić (2014)
10.4333/KPS.2010.40.6.321
In vitro Nasal Cell Culture Systems for Drug Transport Studies
Hyun-Jong Cho (2010)
10.1039/c9py01120j
Real time monitoring of peptide delivery in vitro using high payload pH responsive nanogels
Shegufta N. Farazi (2020)
10.1016/j.ejpb.2014.03.004
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Ana Fortuna (2014)
10.1201/B12778-8
Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases
D. Paturi (2012)
10.1016/j.ijpharm.2018.10.029
Advanced formulations for intranasal delivery of biologics
J. Rohrer (2018)
Skin Drug Delivery From Different Lipid Vesicular Systems
Ming Chen (2011)
10.3109/08982104.2014.899366
Effect of lyophilization on liposomal encapsulation of salmon calcitonin
Janani Swaminathan (2014)
10.1155/2013/161943
Enhanced Topical Delivery of Tetrandrine by Ethosomes for Treatment of Arthritis
C. Fan (2013)
10.2174/0929867326666190827151741
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
Areen Alshweiat (2019)
10.1080/02652048.2020.1826590
Novel lipid–polymer hybrid nanoparticles incorporated in thermosensitive in situ gel for intranasal delivery of terbutaline sulphate
Soha F. Mohamed (2020)
10.1016/j.ijpharm.2016.02.038
Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies.
Ghada M El-Zaafarany (2016)
Semantic Scholar Logo Some data provided by SemanticScholar